Literature DB >> 15937633

Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice.

A El Maghraoui1, A A Do Santos Zounon, I Jroundi, A Nouijai, M Ghazi, L Achemlal, A Bezza, M A Tazi, R Abouqual.   

Abstract

Bone mineral density (BMD) measurements are frequently performed repeatedly for each patient. Subsequent BMD measurements allow reproducibility to be assessed. Previous studies have suggested that reproducibility may be influenced by age and clinical status. The purpose of the study was to examine the reproducibility of BMD by dual energy X-ray absorptiometry (DXA) and to investigate the practical value of different measures of reproducibility in three distinct groups of subjects: healthy young volunteers, postmenopausal women and patients with chronic rheumatic diseases. Two hundred twenty-two subjects underwent two subsequent BMD measurements of the spine and hip. There were 60 young healthy subjects, 102 postmenopausal women and 60 patients with chronic rheumatic diseases (33 rheumatoid arthritis, 10 ankylosing spondylitis and 10 other systemic diseases). Forty-five patients (75%) among the third group were receiving corticosteroids. Reproducibility was expressed as the smallest detectable difference (SDD), coefficient of variation (CV), least significant change (LSC) and intraclass correlation coefficient (ICC). Sources of variation were investigated by linear regression analysis. The median interval between measurements was 0 days (range 0-7). The mean difference (SD) between the measurements (g/cm2) was -0.0001 (+/-0.003) and -0.0004 (+/-0.002) at L1-L4 and the total hip, respectively. At L1-L4 and the total hip, SDD (g/cm2) was +/-0.04 and +/-0.02, CV (%) was 2.02 and 1.29, and LSC (%) 5.60 and 3.56, respectively. The ICC at the spine and hip was 0.99 and 0.99, respectively. Only a minimal difference existed between the groups. Reproducibility in the three groups studied was good. In a repeated DXA scan, a BMD change, the least significant change (LSC) or the SDD should be regarded as significant. Use of the SDD is preferable to use of the CV and LSC because of its independence from BMD and its expression in absolute units. Expressed as SDD, a BMD change of at least +/-0.04 g/cm2 at L1-L4 and +/-0.02 g/cm2 at the total hip should be considered significant. This reproducibility seems independent from age and clinical status and improved in the hips by measuring the dual femur.

Entities:  

Mesh:

Year:  2005        PMID: 15937633     DOI: 10.1007/s00198-005-1916-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Monitoring skeletal changes by radiological techniques.

Authors:  C C Glüer
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

Review 2.  Overview of osteoporosis: pathophysiology and determinants of bone strength.

Authors:  Christopher M Bono; Thomas A Einhorn
Journal:  Eur Spine J       Date:  2003-09-12       Impact factor: 3.134

Review 3.  [Corticosteroid-induced osteoporosis].

Authors:  Abdellah El Maghraoui
Journal:  Presse Med       Date:  2004-10-09       Impact factor: 1.228

Review 4.  Assessment of bone density and bone loss.

Authors:  R Eastell
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis.

Authors:  J A Kanis; O Johnell; A Oden; B Jonsson; C De Laet; A Dawson
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

7.  Prevention and management of osteoporosis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2003

8.  Short-term reproducibility of proximal femur bone mineral density in the elderly.

Authors:  D Maggio; E V McCloskey; L Camilli; S Cenci; A Cherubini; J A Kanis; U Senin
Journal:  Calcif Tissue Int       Date:  1998-10       Impact factor: 4.333

Review 9.  Management of corticosteroid-induced osteoporosis.

Authors:  S S Yeap; D J Hosking
Journal:  Rheumatology (Oxford)       Date:  2002-10       Impact factor: 7.580

10.  Reproducibility of DXA absorptiometry: a model for bone loss estimates.

Authors:  G E Fuleihan; M A Testa; J E Angell; N Porrino; M S Leboff
Journal:  J Bone Miner Res       Date:  1995-07       Impact factor: 6.741

View more
  28 in total

1.  Femoral Neck External Size but not aBMD Predicts Structural and Mass Changes for Women Transitioning Through Menopause.

Authors:  Karl J Jepsen; Andrew Kozminski; Erin Mr Bigelow; Stephen H Schlecht; Robert W Goulet; Sioban D Harlow; Jane A Cauley; Carrie Karvonen-Gutierrez
Journal:  J Bone Miner Res       Date:  2017-01-30       Impact factor: 6.741

2.  Prevalence and risk factors of discordance in diagnosis of osteoporosis using spine and hip bone densitometry.

Authors:  Abdellah El Maghraoui; Davy A Mouinga Abayi; Imad Ghozlani; Aziza Mounach; Abderrazak Nouijai; Mirieme Ghazi; Lahsen Achemlal; Ahmed Bezza
Journal:  Ann Rheum Dis       Date:  2007-02       Impact factor: 19.103

3.  Prevalence and risk factors of osteoporosis in patients with Parkinson's disease.

Authors:  A Bezza; Z Ouzzif; H Naji; L Achemlal; A Mounach; M Nouijai; A Bourazza; R Mossadeq; A El Maghraoui
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

4.  Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women.

Authors:  Zhor Ouzzif; Khalid Oumghar; Karim Sbai; Aziza Mounach; El Mustapha Derouiche; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2010-07-31       Impact factor: 2.631

5.  Efficacy of home-based virtual cycling training on bone mineral density in ambulatory children with cerebral palsy.

Authors:  C-L Chen; C-Y Chen; M-Y Liaw; C-Y Chung; C-J Wang; W-H Hong
Journal:  Osteoporos Int       Date:  2012-09-28       Impact factor: 4.507

6.  Comparison of BMD precision for Prodigy and Delphi spine and femur scans.

Authors:  J A Shepherd; B Fan; Y Lu; E M Lewiecki; P Miller; H K Genant
Journal:  Osteoporos Int       Date:  2006-07-06       Impact factor: 4.507

7.  Performance of the osteoporosis risk assessment tool in Moroccan men.

Authors:  Mirieme Ghazi; Aziza Mounach; Abderrazak Nouijai; Imad Ghozlani; Loubna Bennani; Lahsen Achemlal; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2007-04-03       Impact factor: 2.980

8.  Performance of calcaneus quantitative ultrasound and dual-energy X-ray absorptiometry in the discrimination of prevalent asymptomatic osteoporotic fractures in postmenopausal women.

Authors:  A El Maghraoui; F Morjane; A Mounach; M Ghazi; A Nouijai; L Achemlal; A Bezza; I Ghozlani
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

9.  Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients.

Authors:  Africa Muxí; José-Vicente Torregrosa; David Fuster; Pilar Peris; Sergi Vidal-Sicart; Oriol Solá; Beatriz Domenech; Gloria Martín; Joan Casellas; Francisca Pons
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

10.  Osteoporosis in chronic liver disease: a case-control study.

Authors:  Ghizlane Wariaghli; Aziza Mounach; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2009-07-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.